Grifols, a global healthcare company and manufacturer of plasma-derived medicines, has entered a collaboration agreement with Google Cloud to leverage technologies such as artificial intelligence (AI) to help accelerate the development of new biopharma medicines.   AI featuring large language models will be applied across the drug-development life cycle, including identifying potential therapeutic candidates and managing clinical trial programs, with the goal of significantly reducing the time...